Table: Hisamitsu -2016/17 parent results
Apr 7 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Feb 28, 2017 Feb 29, 2016 Feb 28, 2018 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 112.67 119.31
(-5.6 pct) (-0.6 pct)
Operating 21.54 25.69
(-16.1 pct) (-2.4 pct)
Recurring 22.71 26.30
(-13.6 pct) (-5.5 pct)
Net 16.74 16.93
(-1.1 pct) (-8.1 pct)
EPS 197.98 yen 198.71 yen
EPS Diluted 197.88 yen 198.65 yen
Ann Div 81.50 yen 81.00 yen 82.00 yen
-Q2 Div 40.50 yen 40.00 yen 41.00 yen
-Q4 Div 41.00 yen 41.00 yen 41.00 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO